Riddell Alastair 4/A
4/A · AzurRx BioPharma, Inc. · Filed Jun 21, 2019
Insider Transaction Report
Form 4/AAmended
Riddell Alastair
Director
Transactions
- Award
Options
2019-06-13+30,000→ 30,000 totalExercise: $1.75Exp: 2024-06-13→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Options will vest in quarterly installments over a one-year period beginning on June 30, 2019.